【摘要】：近年來,甲狀腺癌發(fā)病率呈明顯上升趨勢。手術(shù)是治療甲狀腺癌最主要的手段。分化型甲狀腺癌(DTC)總體預(yù)后較好,但甲狀腺癌術(shù)后約30%病人會出現(xiàn)復(fù)發(fā)或轉(zhuǎn)移,終生規(guī)范化隨訪和監(jiān)控尤為重要。隨訪內(nèi)容包括甲狀腺功能的測定、甲狀腺球蛋白(Tg)測定、頸部超聲及131I全身掃描、18-氟脫氧葡萄糖正電子發(fā)射計算機斷層掃描(18FDG PET)等。規(guī)范化長期隨訪動態(tài)觀察病情進(jìn)展,早期發(fā)現(xiàn)腫瘤復(fù)發(fā)及轉(zhuǎn)移,監(jiān)控治療效果并及時調(diào)整治療方案,對降低DTC病死率意義重大,甲狀腺癌術(shù)后規(guī)范化管理勢在必行。
[Abstract]:In recent years, the incidence of thyroid cancer has increased significantly. Surgery is the most important treatment for thyroid cancer. The overall prognosis of differentiated thyroid carcinoma (DTC) is good, but about 30% of patients with thyroid carcinoma will have recurrence or metastasis after operation. It is very important to follow up and monitor thyroid carcinoma for life. The follow-up included thyroid function, thyroid globulin (Tg), cervical ultrasound and 131I whole body scan, 18 fluorodeoxyglucose positron emission computed tomography (18FDG PET) and so on. Standardized long-term follow-up and dynamic observation of the progress of the disease, early detection of tumor recurrence and metastasis, monitoring the therapeutic effect and timely adjustment of the treatment plan are of great significance to reduce the mortality of DTC. It is imperative to standardize the management of thyroid cancer after operation.
【作者單位】： 中國人民解放軍總醫(yī)院普通外科;
【分類號】：R736.1

【相似文獻(xiàn)】

相關(guān)期刊論文 前2條

1 陳霖;楊勇;徐偉;楊宏新;成綏生;高維實;;BARD1和Aurora-A在甲狀腺癌中的表達(dá)及意義[J];內(nèi)蒙古醫(yī)學(xué)雜志;2014年05期

2 薛江;張瑞明;;甲狀腺癌術(shù)前診斷的研究進(jìn)展[J];內(nèi)蒙古醫(yī)學(xué)雜志;2014年05期

相關(guān)博士學(xué)位論文 前1條

1 趙健潔;長鏈非編碼RNA-ANRIL通過TGF beta/Smad信號通路調(diào)控甲狀腺癌細(xì)胞侵襲和轉(zhuǎn)移研究[D];第三軍醫(yī)大學(xué);2017年

，

本文編號：2311551